Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3907604
Max Phase: Preclinical
Molecular Formula: C4H4Na2O4
Molecular Weight: 162.05
Molecule Type: Small molecule
Associated Items:
ID: ALA3907604
Max Phase: Preclinical
Molecular Formula: C4H4Na2O4
Molecular Weight: 162.05
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C([O-])CCC(=O)[O-].[Na+].[Na+]
Standard InChI: InChI=1S/C4H6O4.2Na/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2
Standard InChI Key: ZDQYSKICYIVCPN-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 162.05 | Molecular Weight (Monoisotopic): 161.9905 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2001) Identification of modulators of GPR41 or GPR42 activity, |
Source(1):